This article was written by Follow Vasily Zyryanov is an individual investor and writer.He uses various techniques to find both relatively underpriced equities with...
This article was written by Follow David A. Johnson is founder and principal of Endurance Capital Management, a New Jersey Limited Liability Company. As...
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds and exchange-traded...
Using a digital advertising strategy is now largely the default option for most organizations, outside of a few very niche markets. The benefits offered...
Sarepta Therapeutics (NASDAQ:SRPT) is a large (~$14 billion market cap) biopharmaceutical company that markets 3 RNA-targeted products for Duchenne muscular dystrophy (DMD) patients. In...